Matches in SemOpenAlex for { <https://semopenalex.org/work/W2414963325> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W2414963325 endingPage "80" @default.
- W2414963325 startingPage "S177" @default.
- W2414963325 abstract "DAB486IL-2 is the first of a new class of targeted biologicals called fusion toxins. This agent is an interleukin-2 receptor (IL-2R)-targeted cytotoxin which kills activated IL-2R-expressing lymphocytes at 10(-10) M concentrations. Since activated lymphocytes are thought to play a role in many autoimmune conditions, DAB486IL-2 has been evaluated in patients with severe rheumatoid arthritis and recent onset autoimmune insulin-dependent diabetes mellitus. Initial safety, pharmacokinetics and evidence of IL-2R specific cytotoxicity were obtained in patients with IL-2 receptor expressing malignancies; these studies served as a basis for the initiation of an open label phase I/II evaluation of DAB486IL-2 in patients with severe, methotrexate refractory rheumatoid arthritis. This pilot study provided preliminary evidence of acceptable safety at doses which induced meaningful (> 25%) or substantial (> 50%) improvement in 9 of 18 patients who received a mid (130 kU/kg/d) or a high (260 kU/kg/d) dose daily for 5 to 7 days. The most frequent adverse effects were transient hepatic transminase elevation and fever. Although some patients noted a transient increase in joint pain, onset of improvement occurred within 7 to 14 days of initiation of DAB486IL-2. Because of these results, a two-center, double-blind, placebo-controlled trial was conducted from December 1991 to December 1992. Forty-five patients with active severe RA unresponsive to at least 2 DMARDS were randomized to placebo or DAB486IL-2 following a 3 to 4 week washout/run-in period to establish a stable baseline (< 40% fluctuation in swollen and painful, tender joint counts).(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
- W2414963325 created "2016-06-24" @default.
- W2414963325 creator A5071494532 @default.
- W2414963325 date "1993-03-01" @default.
- W2414963325 modified "2023-09-25" @default.
- W2414963325 title "Early clinical studies of IL-2 fusion toxin in patients with severe rheumatoid arthritis and recent onset insulin-dependent diabetes mellitus." @default.
- W2414963325 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8324945" @default.
- W2414963325 hasPublicationYear "1993" @default.
- W2414963325 type Work @default.
- W2414963325 sameAs 2414963325 @default.
- W2414963325 citedByCount "2" @default.
- W2414963325 crossrefType "journal-article" @default.
- W2414963325 hasAuthorship W2414963325A5071494532 @default.
- W2414963325 hasConcept C126322002 @default.
- W2414963325 hasConcept C134018914 @default.
- W2414963325 hasConcept C142724271 @default.
- W2414963325 hasConcept C197934379 @default.
- W2414963325 hasConcept C203014093 @default.
- W2414963325 hasConcept C204787440 @default.
- W2414963325 hasConcept C27081682 @default.
- W2414963325 hasConcept C2777077863 @default.
- W2414963325 hasConcept C2777575956 @default.
- W2414963325 hasConcept C2779306644 @default.
- W2414963325 hasConcept C2781059491 @default.
- W2414963325 hasConcept C555293320 @default.
- W2414963325 hasConcept C71924100 @default.
- W2414963325 hasConcept C90924648 @default.
- W2414963325 hasConceptScore W2414963325C126322002 @default.
- W2414963325 hasConceptScore W2414963325C134018914 @default.
- W2414963325 hasConceptScore W2414963325C142724271 @default.
- W2414963325 hasConceptScore W2414963325C197934379 @default.
- W2414963325 hasConceptScore W2414963325C203014093 @default.
- W2414963325 hasConceptScore W2414963325C204787440 @default.
- W2414963325 hasConceptScore W2414963325C27081682 @default.
- W2414963325 hasConceptScore W2414963325C2777077863 @default.
- W2414963325 hasConceptScore W2414963325C2777575956 @default.
- W2414963325 hasConceptScore W2414963325C2779306644 @default.
- W2414963325 hasConceptScore W2414963325C2781059491 @default.
- W2414963325 hasConceptScore W2414963325C555293320 @default.
- W2414963325 hasConceptScore W2414963325C71924100 @default.
- W2414963325 hasConceptScore W2414963325C90924648 @default.
- W2414963325 hasLocation W24149633251 @default.
- W2414963325 hasOpenAccess W2414963325 @default.
- W2414963325 hasPrimaryLocation W24149633251 @default.
- W2414963325 hasRelatedWork W185090239 @default.
- W2414963325 hasRelatedWork W2000962647 @default.
- W2414963325 hasRelatedWork W2118084423 @default.
- W2414963325 hasRelatedWork W2159798671 @default.
- W2414963325 hasRelatedWork W2401514108 @default.
- W2414963325 hasRelatedWork W2414220780 @default.
- W2414963325 hasRelatedWork W2559743688 @default.
- W2414963325 hasRelatedWork W2783466784 @default.
- W2414963325 hasRelatedWork W3150149790 @default.
- W2414963325 hasRelatedWork W70445611 @default.
- W2414963325 hasVolume "11 Suppl 8" @default.
- W2414963325 isParatext "false" @default.
- W2414963325 isRetracted "false" @default.
- W2414963325 magId "2414963325" @default.
- W2414963325 workType "article" @default.